• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IgA 肾病中 IgA1 分子的异常糖基化。

Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy.

机构信息

Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL..

Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK.

出版信息

Semin Nephrol. 2018 Sep;38(5):461-476. doi: 10.1016/j.semnephrol.2018.05.016.

DOI:10.1016/j.semnephrol.2018.05.016
PMID:30177018
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7170174/
Abstract

IgA nephropathy, the most common primary glomerulonephritis in the world and a frequent cause of end-stage renal disease, is characterized by typical mesangial deposits of IgA1, as described by Berger and Hinglaise in 1968. Since then, it has been discovered that aberrant IgA1 O-glycosylation is involved in disease pathogenesis. Progress in glycomic, genomic, clinical, analytical, and biochemical studies has shown autoimmune features of IgA nephropathy. The autoimmune character of the disease is explained by a multihit pathogenesis model, wherein overproduction of aberrantly glycosylated IgA1, galactose-deficient in some O-glycans, by IgA1-secreting cells leads to increased levels of circulatory galactose-deficient IgA1. These glycoforms induce production of autoantibodies that subsequently bind hinge-region of galactose-deficient IgA1 molecules, resulting in the formation of nephritogenic immune complexes. Some of these complexes deposit in the kidney, activate mesangial cells, and incite glomerular injury. Thus, galactose-deficient IgA1 is central to the disease process. In this article, we review studies concerning IgA1 O-glycosylation that have contributed to the current understanding of the role of IgA1 in the pathogenesis of IgA nephropathy.

摘要

IgA 肾病是世界上最常见的原发性肾小球肾炎,也是终末期肾病的常见病因,其特征是 Berger 和 Hinglaise 于 1968 年描述的典型系膜 IgA1 沉积。从那时起,人们发现异常的 IgA1 O-糖基化参与了疾病的发病机制。糖组学、基因组学、临床、分析和生化研究的进展表明 IgA 肾病具有自身免疫特征。疾病的自身免疫特征可以用多打击发病机制模型来解释,即在 IgA1 分泌细胞中,异常糖基化 IgA1 的过度产生和某些 O-聚糖中的半乳糖缺乏导致循环中半乳糖缺乏 IgA1 的水平升高。这些糖型诱导产生自身抗体,随后与半乳糖缺乏 IgA1 分子的铰链区结合,导致肾炎性免疫复合物的形成。其中一些复合物沉积在肾脏中,激活系膜细胞,并引发肾小球损伤。因此,半乳糖缺乏的 IgA1 是疾病过程的核心。本文综述了有关 IgA1 O-糖基化的研究,这些研究有助于我们当前对 IgA1 在 IgA 肾病发病机制中的作用的理解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25d4/7170174/a17e8ed81169/nihms-1500475-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25d4/7170174/021591fec485/nihms-1500475-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25d4/7170174/42ccbee4d49d/nihms-1500475-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25d4/7170174/640462ae4909/nihms-1500475-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25d4/7170174/a17e8ed81169/nihms-1500475-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25d4/7170174/021591fec485/nihms-1500475-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25d4/7170174/42ccbee4d49d/nihms-1500475-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25d4/7170174/640462ae4909/nihms-1500475-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25d4/7170174/a17e8ed81169/nihms-1500475-f0004.jpg

相似文献

1
Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy.IgA 肾病中 IgA1 分子的异常糖基化。
Semin Nephrol. 2018 Sep;38(5):461-476. doi: 10.1016/j.semnephrol.2018.05.016.
2
O-glycosylation of IgA1 and the pathogenesis of an autoimmune disease IgA nephropathy.IgA1 的 O-糖基化与自身免疫性疾病 IgA 肾病的发病机制。
Glycobiology. 2024 Sep 30;34(11). doi: 10.1093/glycob/cwae060.
3
IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells.IgA肾病和过敏性紫癜性肾炎:IgA1糖基化异常、含IgA1免疫复合物的形成以及系膜细胞的激活。
Contrib Nephrol. 2007;157:134-8. doi: 10.1159/000102455.
4
Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.IgA肾病中IgA1的异常糖基化和抗聚糖抗体:黏膜免疫系统的作用
Adv Otorhinolaryngol. 2011;72:60-3. doi: 10.1159/000324607. Epub 2011 Aug 18.
5
Cellular signaling and production of galactose-deficient IgA1 in IgA nephropathy, an autoimmune disease.IgA 肾病(一种自身免疫性疾病)中细胞信号转导和半乳糖缺乏 IgA1 的产生。
J Immunol Res. 2014;2014:197548. doi: 10.1155/2014/197548. Epub 2014 Jul 23.
6
Glycosylation of IgA1 and pathogenesis of IgA nephropathy.IgA1 的糖基化与 IgA 肾病的发病机制。
Semin Immunopathol. 2012 May;34(3):365-82. doi: 10.1007/s00281-012-0306-z. Epub 2012 Mar 21.
7
Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study.N-乙酰半乳糖胺特异性蜗牛凝集素识别 IgA1 铰链区的半乳糖缺乏型 O-聚糖:比较结合研究。
Biochemistry. 2010 Jul 13;49(27):5671-82. doi: 10.1021/bi9019498.
8
IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy.IgA糖基化与IgA免疫复合物在IgA肾病发病机制中的作用
Semin Nephrol. 2008 Jan;28(1):78-87. doi: 10.1016/j.semnephrol.2007.10.009.
9
The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy.IgA1 O-连接糖基化在IgA肾病发病机制中的致病作用。
Nephrology (Carlton). 2007 Jun;12(3):275-84. doi: 10.1111/j.1440-1797.2007.00797.x.
10
[IgA1 aberrant glycosylation in the pathogenesis of IgA nephropathy: an overivew].[IgA1异常糖基化在IgA肾病发病机制中的研究概述]
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2010 Feb;27(1):227-30.

引用本文的文献

1
species on the tonsillar surface predicts favorable clinical outcomes in patients with Immunoglobulin A nephropathy who underwent tonsillectomy.扁桃体表面的菌种可预测接受扁桃体切除术的IgA肾病患者的良好临床结局。
Ren Fail. 2025 Dec;47(1):2550617. doi: 10.1080/0886022X.2025.2550617. Epub 2025 Sep 3.
2
The Role of Glycans in Human Immunity-A Sweet Code.聚糖在人类免疫中的作用——一个甜蜜的密码。
Molecules. 2025 Jun 20;30(13):2678. doi: 10.3390/molecules30132678.
3
Lysosome-mediated aggregation of galactose-deficient IgA1 with transferrin receptor 1 links to IgA nephropathy.

本文引用的文献

1
Glomerular Immunodeposits of Patients with IgA Nephropathy Are Enriched for IgG Autoantibodies Specific for Galactose-Deficient IgA1.IgA 肾病患者肾小球免疫沉积物富含针对半乳糖缺乏 IgA1 的 IgG 自身抗体。
J Am Soc Nephrol. 2019 Oct;30(10):2017-2026. doi: 10.1681/ASN.2018111156. Epub 2019 Aug 23.
2
Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy.抑制STAT3信号传导可减少IgA肾病中IgA1自身抗原的产生。
Kidney Int Rep. 2017 Jul 19;2(6):1194-1207. doi: 10.1016/j.ekir.2017.07.002. eCollection 2017 Nov.
3
Mesangial C4d Deposits in Early IgA Nephropathy.
溶酶体介导的半乳糖缺乏型IgA1与转铁蛋白受体1的聚集与IgA肾病相关。
Nat Commun. 2025 Jul 1;16(1):5536. doi: 10.1038/s41467-025-60819-w.
4
A Bacteroides thetaiotaomicron genetic locus encodes activities consistent with mucin O-glycoprotein processing and N-acetylgalactosamine metabolism.一种多形拟杆菌基因位点编码的活性与粘蛋白O-糖蛋白加工和N-乙酰半乳糖胺代谢一致。
Nat Commun. 2025 Apr 12;16(1):3485. doi: 10.1038/s41467-025-58660-2.
5
Case report: a rare concurrence of dense deposit disease in an adolescent patient with IgA nephropathy.病例报告:一名青少年IgA肾病患者罕见地并发致密物沉积病。
BMC Pediatr. 2025 Jan 20;25(1):47. doi: 10.1186/s12887-025-05415-z.
6
Glycosylation signature of plasma IgA of critically ill COVID-19 patients.危重症 COVID-19 患者血浆 IgA 的糖基化特征。
Front Immunol. 2024 Oct 24;15:1439248. doi: 10.3389/fimmu.2024.1439248. eCollection 2024.
7
My lifetime in IgA nephropathy: An unexpected journey.我在IgA肾病领域的生涯:一段意想不到的旅程。
Nephrology (Carlton). 2024 Sep;29 Suppl 2(Suppl 2):55-59. doi: 10.1111/nep.14341.
8
Lactobacillus casei Cell Wall Extract and Production of Galactose-Deficient IgA1 in a Humanized IGHA1 Mouse Model.干酪乳杆菌细胞壁提取物与人源化IGHA1小鼠模型中半乳糖缺陷型IgA1的产生
J Am Soc Nephrol. 2025 Jan 1;36(1):60-72. doi: 10.1681/ASN.0000000000000465. Epub 2024 Aug 22.
9
O-glycosylation of IgA1 and the pathogenesis of an autoimmune disease IgA nephropathy.IgA1 的 O-糖基化与自身免疫性疾病 IgA 肾病的发病机制。
Glycobiology. 2024 Sep 30;34(11). doi: 10.1093/glycob/cwae060.
10
Stability Engineering of Recombinant Secretory IgA.重组分泌型 IgA 的稳定性工程。
Int J Mol Sci. 2024 Jun 22;25(13):6856. doi: 10.3390/ijms25136856.
早期 IgA 肾病中的系膜 C4d 沉积。
Clin J Am Soc Nephrol. 2018 Feb 7;13(2):258-264. doi: 10.2215/CJN.02530317. Epub 2017 Nov 16.
4
Toll-like receptors: Significance, ligands, signaling pathways, and functions in mammals.Toll 样受体:在哺乳动物中的意义、配体、信号通路和功能。
Int Rev Immunol. 2018 Jan 2;37(1):20-36. doi: 10.1080/08830185.2017.1380200. Epub 2017 Oct 13.
5
Location of glomerular immune deposits, not codeposition of immunoglobulin G, influences definitive renal outcomes in immunoglobulin A nephropathy.肾小球免疫沉积物的位置,而非免疫球蛋白 G 的共沉积,影响免疫球蛋白 A 肾病的明确肾脏结局。
Nephrol Dial Transplant. 2018 Jul 1;33(7):1168-1175. doi: 10.1093/ndt/gfx238.
6
β1,4-galactosyltransferase 1 is a novel receptor for IgA in human mesangial cells.β1,4-半乳糖基转移酶 1 是人类肾小球系膜细胞中 IgA 的新型受体。
Kidney Int. 2017 Dec;92(6):1458-1468. doi: 10.1016/j.kint.2017.05.002. Epub 2017 Jul 24.
7
What insights can proteomics give us into IgA nephropathy (Berger's disease)?蛋白质组学能为我们提供哪些关于IgA肾病(伯杰氏病)的见解?
Expert Rev Proteomics. 2017 Aug;14(8):645-647. doi: 10.1080/14789450.2017.1331738. Epub 2017 May 29.
8
Galactosylation of IgA1 Is Associated with Common Variation in .IgA1的半乳糖基化与……中的常见变异相关。
J Am Soc Nephrol. 2017 Jul;28(7):2158-2166. doi: 10.1681/ASN.2016091043. Epub 2017 Feb 16.
9
GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway.血清半乳糖缺陷型IgA1的全基因组关联研究揭示了O-糖基化途径的关键基因。
PLoS Genet. 2017 Feb 10;13(2):e1006609. doi: 10.1371/journal.pgen.1006609. eCollection 2017 Feb.
10
Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?半乳糖缺陷型IgA1作为IgA肾病的候选尿多肽标志物?
Dis Markers. 2016;2016:7806438. doi: 10.1155/2016/7806438. Epub 2016 Aug 28.